Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapdap vs Coartemether for Uncomplicated Malaria
NCT00118794Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chlorproguanil + dapsone in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Clinical failure at 28 days. Started Sep 2004; status: completed.
02
Drugs
chlorproguanil + dapsone
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00118794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118794.